Down syndrome maternal serum screening in patients with renal disease

被引：7
作者：
Benachi, Alexandra [2 ]
Dreux, Sophie [1 ]
Kaddioui-Maalej, Sahar [2 ]
Czerkiewicz, Isabelle [1 ]
Fakhouri, Fadi [3 ]
Thervet, Eric [4 ]
Muller, Francoise [1 ]
机构：
[1] Univ Paris Ile France Ouest, Dept Biochem, Hop Robert Debre, Assistance Publ Hop Paris, F-75019 Paris, France
[2] Univ Paris 05, Dept Obstet & Gynecol, Hop Necker Enfants Malad, Assistance Publ Hop Paris, Paris, France
[3] Assistance Publ Hop Paris, Dept Nephrol, Hop Necker Enfants Malad, Paris, France
[4] Assistance Publ Hop Paris, Dept Renal Transplantat, Hop Necker Enfants Malad, Paris, France
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2010年 / 203卷 / 01期
关键词：
pregnancy; prenatal diagnosis; renal failure; trisomy; 21; NUCHAL TRANSLUCENCY; GONADOTROPIN; PREGNANCY; CREATININE; MARKER;
D O I：
10.1016/j.ajog.2010.01.080
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
OBJECTIVE: The objective of the study was to determine the value of maternal serum Down syndrome screening in patients affected by renal disease. STUDY DESIGN: A study group of 54 pregnant women with renal diseases defined before pregnancy, was compared with a control group of 108 patients matched for maternal age, maternal weight, smoking status, and gestational age. Maternal serum markers (free beta-human chorionic gonadotropin [hCG], total hCG, alpha-fetoprotein) expressed in multiple of median and maternal renal function markers (creatinine, beta 2-microglobulin, alpha 1-microglobulin) were assayed. RESULTS: The percentage of patients in the Down syndrome at-risk group (>1:250) using free beta-hCG was significantly higher (P < .02) in the renal disease group (48%) than in the control group (12%). No significant difference was observed for total hCG (25% vs 15%). CONCLUSION: Down syndrome screening using free beta-hCG is not applicable in patients with renal disease whatever the maternal serum creatinine and can be used with caution when total hCG is used.
引用
收藏
页码：60.e1 / 60.e4
页数：4
相关论文
共 50 条
[41]   Screening for Down syndrome: changing practice of obstetricians [J].
Driscoll, Deborah A. ;
Morgan, Maria A. ;
Schulkin, Jay .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (04) :459.e1-459.e9
[42]   Stability of maternal serum free β-hCG following whole blood sample transit: First trimester Down's syndrome screening in Scotland [J].
Ballantyne, Angela ;
Rashid, Lorna ;
Pattenden, Rebecca .
ANNALS OF CLINICAL BIOCHEMISTRY, 2022, 59 (01) :87-91
[43]   Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters [J].
Zhang, Jing ;
Lambert-Messerlian, Geralyn ;
Palomaki, Glenn E. ;
Canick, Jacob A. .
PRENATAL DIAGNOSIS, 2011, 31 (06) :583-588
[44]   First trimester maternal serum screening using biochemical markers PAPP-A and Free β-hCG for down syndrome, patau syndrome and edward syndrome [J].
Shiefa S. ;
Amargandhi M. ;
Bhupendra J. ;
Moulali S. ;
Kristine T. .
Indian Journal of Clinical Biochemistry, 2013, 28 (1) :3-12
[45]   Down syndrome screening in the first and second trimesters: What do the data show? [J].
Rosen, T ;
D'Alton, ME .
SEMINARS IN PERINATOLOGY, 2005, 29 (06) :367-375
[46]   Herman score in prenatal screening for Down syndrome: Can a junior assess a senior? [J].
Hamdaoui, N. ;
Lesieur, E. ;
Mancini, J. ;
Dabadie, A. ;
Bourderionnet, V. ;
Pico, H. ;
Colombani, M. ;
Bretelle, F. ;
Gorincour, G. .
DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2017, 98 (02) :155-160
[47]   A new mutation in the AFP gene responsible for a total absence of alpha feto-protein on second trimester maternal serum screening for Down syndrome [J].
Petit, Francois M. ;
Hebert, Marylise ;
Picone, Olivier ;
Brisset, Sophie ;
Maurin, Marie-Laure ;
Parisot, Frederic ;
Capel, Liliane ;
Benattar, Clarisse ;
Senat, Marie-Victoire ;
Tachdjian, Gerard ;
Labrune, Philippe .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2009, 17 (03) :387-390
[48]   Prenatal screening for Down's syndrome with maternal markers: Tunisian experience [J].
Ferchichi, S. ;
Chahed, H. ;
Jaidane, Z. ;
Chaabouni, Y. ;
Saafi, N. ;
Limem, H. B. ;
Sakouhi, M. ;
Bernard, M. ;
Khairi, H. ;
Laradi, S. ;
Miled, A. .
IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2010, 25 (04) :205-211
[49]   Biochemical screening for Down syndrome in pregnancies following renal transplantation [J].
Karidas, CN ;
Michailidis, GD ;
Spencer, K ;
Economides, DL .
PRENATAL DIAGNOSIS, 2002, 22 (03) :226-230
[50]   Serum screening for Down syndrome and adverse pregnancy outcomes: a case-controlled study [J].
Ogle, R ;
Jauniaux, E ;
Pahal, GS ;
Dell, E ;
Sheldrake, A ;
Rodeck, C .
PRENATAL DIAGNOSIS, 2000, 20 (02) :96-99
12345